Ospedale Centrale di Bolzano — Bolzano, BZ

Public research footprint of Ospedale Centrale di Bolzano, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-Cell Lymphoma · Non Small Cell Lung Cancer (NSCLC) · Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) · Classical Hodgkin Lymphoma

Recently updated registry entries

NCT07727070 — Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to… (Active Not Recruiting)
NCT03610438 — Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic… (Active Not Recruiting)
NCT05756621 — Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ospedale Centrale di Bolzano?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.